Effects of xylazine on airway function in ponies with recurrent airway obstruction.

The researchers studied the effects of the drug xylazine on the airway function of ponies diagnosed with recurrent airway obstruction, also known as heaves. They found that xylazine, when administered intravenously, reduced pulmonary resistance and improved dynamic compliance in ponies experiencing an acute airway obstruction episode, with no impact on blood gases.

Study Design and Participants

• The study involved a total of 12 ponies, half of which were diagnosed with recurrent airway obstruction or ‘heaves’ — a common equine respiratory disease similar to human asthma.
• The six ponies suffering from heaves were studied both during a clinical remission period and during an acute attack of airway obstruction that was deliberately precipitated by housing them in a stable and feeding them dusty hay.
• The other six ponies, which were healthy and did not have heaves, were used as control subjects for comparison.

Experimentation and Observations

• All ponies were administered xylazine hydrochloride intravenously at a dosage of 0.5 mg/kg body weight.
• In ponies with active airway obstruction, the administration of xylazine significantly reduced the pulmonary resistance and increased dynamic compliance — the lung’s ability to expand and contract with change in lung volume.
• No significant changes were observed in the levels of arterial oxygen (PaO2) or carbon dioxide (PaCO2), indicating that xylazine did not affect gas exchanges in the lungs.
• The effects of xylazine were counteracted by the administration of yohimbine — a recognized alpha 2-adrenoceptor antagonist — which blocked xylazine’s action, signifying that the observed effects were indeed due to xylazine.
• Administration of a saline solution had no effect on either group of ponies at any time, further reinforcing the effect of xylazine.
• Interestingly, xylazine did not have any significant effect in the control group of ponies or in the heaves-affected ponies during their clinical remission.

Conclusion

• The findings suggest that xylazine could potentially alleviate acute episodes of airway obstruction in ponies with recurrent airway obstruction, also known as ‘heaves’, by reducing pulmonary resistance and improving dynamic compliance.
• However, the drug does not appear to have any beneficial effect when the disease is in remission or in healthy ponies.
• This insight could help veterinarians better manage acute obstruction episodes in ponies with ‘heaves’ and contribute to improving their quality of life, although further studies on longer-term effects and potential side effects of xylazine are necessary to confirm these findings.